{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Sports Desk", "lead_paragraph": "In an effort to dilute the debate over a testosterone-producing pill that Mark McGwire has acknowledged using, the baseball commissioner and the players union chief issued a joint statement yesterday saying that they have asked their medical experts to study the whole area of nutritional supplements. Although the pill, androstenedione, is legal and available over the counter, its use by a baseball player of McGwire's stature has become controversial because it is banned by the International Olympic Committee, the National Football League and the National Collegiate Athletic Association.", "headline": {"main": "Baseball Tries to Calm Down a Debate on Pills", "kicker": "BASEBALL"}, "abstract": "Baseball Commissioner Bud Selig and players union chief Donald Fehr, in an effort to dilute debate over testosterone-producing pill that Mark McGwire has acknowledged using, issue joint statement saying that they have asked their medical experts to study whole area of nutritional supplements (M)", "print_page": "1", "word_count": 723, "_id": "4fd213c78eb7c8105d78b5cb", "snippet": "In an effort to dilute the debate over a testosterone-producing pill that Mark McGwire has acknowledged using, the baseball commissioner and the players union chief issued a joint statement yesterday saying that they have asked their medical experts...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/08/27/sports/baseball-baseball-tries-to-calm-down-a-debate-on-pills.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SELIG, BUD"}, {"name": "persons", "value": "MCGWIRE, MARK"}, {"name": "persons", "value": "FEHR, DONALD"}, {"name": "organizations", "value": "ST LOUIS CARDINALS"}, {"name": "subject", "value": "BASEBALL"}, {"name": "subject", "value": "STEROIDS"}, {"name": "subject", "value": "CREATINE (BIOLOGICAL SUBSTANCE)"}, {"name": "subject", "value": "ANDROSTENEDIONE"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Murray", "lastname": "CHASS"}], "original": "By MURRAY CHASS"}, "document_type": "article", "pub_date": "1998-08-27T00:00:00Z", "section_name": "Sports"}, {"type_of_material": "Biography", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "When Agnes Varis was asked to join the board of Copley Pharmaceutical Inc. in 1992, it was not because she was expected to hold her tongue. As president of her own chemical company in Little Falls, N.J., she had more than two decades of industry experience. And here was a chance to help Copley, a promising maker of generic drugs, become a major player. ''You get a good rush from all of that,'' Ms. Varis said. But that all changed when Hoechst A.G., the big German conglomerate, bought a majority stake in Copley, based in Canton, Mass., the following year. Hoechst did not seem to appreciate Ms. Varis's occasional dissent. ''They look for directors that are 'parsley on the fish,' '' she said in an interview, describing what she regarded as the trivial role Hoechst executives expected the outside directors on the board to play.", "headline": {"main": "THE MARKETS: Market Place -- Outspoken and Out the Door; A Director Quits, Breaking 'the Code' in a Parting Blast"}, "abstract": "Market Place column examines Agnes Varis's reasons for resigning from board of Copley Pharmaceutical Inc; Varis has publicly accused Hoechst AG, majority owner of Copley, of mismanaging company and not acting in best interests of all shareholders; says Hoechst expected outside directors on board to rubber-stamp its decisions regarding Copley; Varis's story illustrates how little power directors often have; Varis's major complaint against Hoechst is that it seemingly thwarted efforts to sell Copley, even after losing interest in it; Copley stock has lost 40 percent of its value in last two years; photo; graph (M)", "print_page": "1", "word_count": 1945, "_id": "4fd1dfe88eb7c8105d725571", "snippet": "When Agnes Varis was asked to join the board of Copley Pharmaceutical Inc. in 1992, it was not because she was expected to hold her tongue. As president of her own chemical company in Little Falls, N.J., she had more than two decades of industry...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/08/26/business/markets-market-place-outspoken-door-director-quits-breaking-code-parting-blast.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "MARKET PLACE (TIMES COLUMN)"}, {"name": "persons", "value": "VARIS, AGNES"}, {"name": "organizations", "value": "HOECHST AG"}, {"name": "organizations", "value": "COPLEY PHARMACEUTICAL INC"}, {"name": "subject", "value": "SUSPENSIONS, DISMISSALS AND RESIGNATIONS"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "COMPANY AND ORGANIZATION PROFILES"}, {"name": "subject", "value": "BOARDS OF DIRECTORS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Reed", "lastname": "ABELSON"}], "original": "By REED ABELSON"}, "document_type": "article", "pub_date": "1998-08-26T00:00:00Z", "section_name": "Business"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONAL A3-10 More Fiscal Panic in Russia As Negotiations Continue A fresh wave of panic swept through Russia's financial institutions as the currency plunged, three banks announced a merger and the Government unveiled a plan to stretch out the repayment of its debt. The developments came as the newly designated Prime Minister, Viktor S. Chernomyrdin, was negotiating with the Parliament over the makeup of his new Government. A1 Egypt Is Said to Hold Terrorist One of the world's most wanted terrorists, the Palestinian guerrilla chief known as Abu Nidal, is being held by Egyptian authorities in Cairo, according to an Arab intelligence official. A1", "headline": {"main": "NEWS SUMMARY"}, "abstract": null, "print_page": "2", "word_count": 1246, "_id": "4fd1ee1c8eb7c8105d741416", "snippet": "INTERNATIONAL   A3-10    More Fiscal Panic in Russia As Negotiations Continue  A fresh wave of panic swept through Russia's financial institutions as the currency plunged, three banks announced a merger and the Government unveiled a plan to stretch...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/08/26/nyregion/news-summary-533068.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "1998-08-26T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "While the risk of a nuclear power plant disaster is very small, state and Federal disaster agencies owe it to people who live near reactors to help them guard against the health dangers of a nuclear leak or meltdown. The availability of potassium iodide pills can help that effort. There is clear evidence that potassium iodide, if taken shortly before or after a nuclear accident, can block the absorption of radioactive iodine, which can cause thyroid cancer. This effect has been known for many years, and the drug was approved by the Food and Drug Administration in 1978. But Federal and state agencies involved with disaster planning, uncertain about health risks of the drug and perhaps not wanting to alarm residents living near nuclear reactors, have not publicized potassium iodide. Data from Poland in the aftermath of the Chernobyl accident, however, have shown that benefits of the drug outweigh risks of side effects.", "headline": {"main": "Drugs for a Nuclear Disaster"}, "abstract": "Editorial says state and Federal disaster agencies should provide people living near nuclear reactors with potassium iodide pills; says pills have been shown to block absorption of radioactive iodine, which causes thyroid cancer, if taken shortly before or after nuclear accident; says aggressive evacuation plans should remain primary response strategy", "print_page": "20", "word_count": 351, "_id": "4fd219058eb7c8105d7965d6", "snippet": "While the risk of a nuclear power plant disaster is very small, state and Federal disaster agencies owe it to people who live near reactors to help them guard against the health dangers of a nuclear leak or meltdown. The availability of potassium...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/08/26/opinion/drugs-for-a-nuclear-disaster.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "ACCIDENTS AND SAFETY"}, {"name": "subject", "value": "THYROID GLAND"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "RADIATION"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "POTASSIUM IODIDE (DRUG)"}, {"name": "subject", "value": "ELECTRIC LIGHT AND POWER"}, {"name": "subject", "value": "ATOMIC ENERGY"}], "byline": null, "document_type": "article", "pub_date": "1998-08-26T00:00:00Z", "section_name": "Health; Opinion"}], "meta": {"hits": 4, "offset": 0, "time": 57}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}